Pub Date : 2020-04-01DOI: 10.1097/ju.0000000000000856
P. Bey, V. Beckendorf, J. Stines
Radiation therapy of prostate carcinoma with a curative intent implies to treat the whole prostate at high dose (at least 66 Gy). According to clinical stage, PSA level, Gleason's score, the clinical target volume may include seminal vesicles and less often pelvic lymph nodes. Microscopic extracapsular extension is found in 15 to 60% of T1-T2 operated on, specially in apex tumors. On contrary, cancers developing from the transitional zone may stay limited to the prostate even with a big volume and with a high PSA level. Zonal anatomy of the prostate identifies internal prostate, including the transitional zone (5% of the prostate in young people). External prostate includes central and peripheral zones. The inferior limit of the prostate is not lower than the inferior border of the pubic symphysis. Clinical and radiological examination: ultrasonography, nuclear magnetic resonance (NMR), CT-scan identify prognostic factors as tumor volume, capsule effraction, seminal vesicles invasion and lymph node extension. The identification of the clinical target volume is now done mainly by CT-Scan which identifies prostate and seminal vesicles. NMR could be helpful to identify more precisely prostate apex. The definition of margins around the clinical target volume has to take in account daily reproducibility and organ motion and of course the maximum tolerable dose for organs at risk.
{"title":"[Prostate cancer].","authors":"P. Bey, V. Beckendorf, J. Stines","doi":"10.1097/ju.0000000000000856","DOIUrl":"https://doi.org/10.1097/ju.0000000000000856","url":null,"abstract":"Radiation therapy of prostate carcinoma with a curative intent implies to treat the whole prostate at high dose (at least 66 Gy). According to clinical stage, PSA level, Gleason's score, the clinical target volume may include seminal vesicles and less often pelvic lymph nodes. Microscopic extracapsular extension is found in 15 to 60% of T1-T2 operated on, specially in apex tumors. On contrary, cancers developing from the transitional zone may stay limited to the prostate even with a big volume and with a high PSA level. Zonal anatomy of the prostate identifies internal prostate, including the transitional zone (5% of the prostate in young people). External prostate includes central and peripheral zones. The inferior limit of the prostate is not lower than the inferior border of the pubic symphysis. Clinical and radiological examination: ultrasonography, nuclear magnetic resonance (NMR), CT-scan identify prognostic factors as tumor volume, capsule effraction, seminal vesicles invasion and lymph node extension. The identification of the clinical target volume is now done mainly by CT-Scan which identifies prostate and seminal vesicles. NMR could be helpful to identify more precisely prostate apex. The definition of margins around the clinical target volume has to take in account daily reproducibility and organ motion and of course the maximum tolerable dose for organs at risk.","PeriodicalId":93921,"journal":{"name":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","volume":"36 1","pages":"560-70"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83615329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-12-01DOI: 10.1016/j.canrad.2019.08.005
A. Burgun
{"title":"[Basis and perspectives of artificial intelligence in radiation therapy].","authors":"A. Burgun","doi":"10.1016/j.canrad.2019.08.005","DOIUrl":"https://doi.org/10.1016/j.canrad.2019.08.005","url":null,"abstract":"","PeriodicalId":93921,"journal":{"name":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77986904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-12-01DOI: 10.1016/j.canrad.2019.07.134
C. Verry, Erika Porcel, Cyrus Chargari, C. Rodriguez-Lafrasse, J. Balosso
{"title":"[Use of nanoparticles as radiosensitizing agents in radiotherapy: State of play].","authors":"C. Verry, Erika Porcel, Cyrus Chargari, C. Rodriguez-Lafrasse, J. Balosso","doi":"10.1016/j.canrad.2019.07.134","DOIUrl":"https://doi.org/10.1016/j.canrad.2019.07.134","url":null,"abstract":"","PeriodicalId":93921,"journal":{"name":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","volume":"68 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86031647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-10-31DOI: 10.1016/j.canrad.2019.06.013
K. Hadadi, M. Hommadi, M. Belemlih, N. Zaghba, Abdelhak Maghous, El-Amin Marnouch, K. A. Saghir, M. Elmarjany, H. Sifat, M. Oukabli, H. Mansouri
{"title":"[Solitary bone plasmocytoma: Experience from the radiotherapy department at Mohammed-V military teaching hospital in Rabat (Morocco)].","authors":"K. Hadadi, M. Hommadi, M. Belemlih, N. Zaghba, Abdelhak Maghous, El-Amin Marnouch, K. A. Saghir, M. Elmarjany, H. Sifat, M. Oukabli, H. Mansouri","doi":"10.1016/j.canrad.2019.06.013","DOIUrl":"https://doi.org/10.1016/j.canrad.2019.06.013","url":null,"abstract":"","PeriodicalId":93921,"journal":{"name":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78687543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-10-12DOI: 10.1016/j.canrad.2019.09.001
D. Gensanne, A. Henni, Y. Lauzin, P. Clarisse, S. Thureau
{"title":"[Inter- and intrafraction imaging during stereotactic body radiation therapy: Which solutions for which tumours?]","authors":"D. Gensanne, A. Henni, Y. Lauzin, P. Clarisse, S. Thureau","doi":"10.1016/j.canrad.2019.09.001","DOIUrl":"https://doi.org/10.1016/j.canrad.2019.09.001","url":null,"abstract":"","PeriodicalId":93921,"journal":{"name":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","volume":"413 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75860110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-10-12DOI: 10.1016/j.canrad.2019.08.008
S. Ferreira, M. Dutreix
{"title":"DNA repair inhibitors to enhance radiotherapy: Progresses and limitations.","authors":"S. Ferreira, M. Dutreix","doi":"10.1016/j.canrad.2019.08.008","DOIUrl":"https://doi.org/10.1016/j.canrad.2019.08.008","url":null,"abstract":"","PeriodicalId":93921,"journal":{"name":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86632617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-10-11DOI: 10.1016/j.canrad.2019.05.016
B. Ledoux, M. Dupont, F. Duplaquet, L. Pirard, S. Ocak, M. Wanet, V. Remouchamps
{"title":"Illustration of a fatal radiation-induced lung aneurysm: Is central lung stereotactic radiotherapy to be banned?","authors":"B. Ledoux, M. Dupont, F. Duplaquet, L. Pirard, S. Ocak, M. Wanet, V. Remouchamps","doi":"10.1016/j.canrad.2019.05.016","DOIUrl":"https://doi.org/10.1016/j.canrad.2019.05.016","url":null,"abstract":"","PeriodicalId":93921,"journal":{"name":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","volume":"51 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89980793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-10-11DOI: 10.1016/j.canrad.2019.09.002
S. Rivera, J. Hannoun-levi
{"title":"Hypofractionated radiation therapy for invasive breast cancer: From moderate to extreme protocols.","authors":"S. Rivera, J. Hannoun-levi","doi":"10.1016/j.canrad.2019.09.002","DOIUrl":"https://doi.org/10.1016/j.canrad.2019.09.002","url":null,"abstract":"","PeriodicalId":93921,"journal":{"name":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","volume":"90 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88277944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-10-04DOI: 10.1016/j.canrad.2019.08.007
Mylène Wespiser, Morgan Goujon, T. Nguyen Tan Hon, T. Maurina, F. Kleinclauss, Gilles Créhange, A. Thiery-Vuillemin
{"title":"[Radiotherapy of oligometastases: Sequences and interactions with systemic therapies, example of kidney cancer].","authors":"Mylène Wespiser, Morgan Goujon, T. Nguyen Tan Hon, T. Maurina, F. Kleinclauss, Gilles Créhange, A. Thiery-Vuillemin","doi":"10.1016/j.canrad.2019.08.007","DOIUrl":"https://doi.org/10.1016/j.canrad.2019.08.007","url":null,"abstract":"","PeriodicalId":93921,"journal":{"name":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81831013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-01DOI: 10.1016/j.canrad.2018.11.004
J. Khalil, S. Chaabi, O. Oberlin, S. Sialiti, L. Hessissen, N. Benjaafar
{"title":"Medulloblastoma in childhood: What effects on neurocognitive functions?","authors":"J. Khalil, S. Chaabi, O. Oberlin, S. Sialiti, L. Hessissen, N. Benjaafar","doi":"10.1016/j.canrad.2018.11.004","DOIUrl":"https://doi.org/10.1016/j.canrad.2018.11.004","url":null,"abstract":"","PeriodicalId":93921,"journal":{"name":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78541570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：